Are Annual GLP-1 Plans Worth It? 2026 Prepay vs Month-to-Month Math

Last reviewed: September 13, 2026 Last updated: September 13, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Annual GLP-1 plans can save $900 to $1,440 over twelve months compared to month-to-month rates, but they require upfront payments ranging from $888 to $2,364 and typically offer no prorated refunds if you stop early. The math works if you're confident in a twelve-month commitment and have the cash to prepay; it breaks down if your dose changes, side effects emerge, or you reach your goal early. Programs that separate membership from medication—such as Ro and WeightWatchers Clinic—add complexity because the advertised annual rate often covers only care, not the drug itself. PlexusDx does not offer annual prepay plans; instead, the service uses flat per-dose pricing and three- or six-month commit periods at lower effective rates, giving you a middle path between flexibility and savings.

At-a-glance: advertised annual rates and what they include

Sources: Found pricing captured September 4, 2026; Ro captured September 4, 2026; Henry Meds captured September 4, 2026; Calibrate captured September 4, 2026; PlushCare captured September 4, 2026; PlexusDx captured September 13, 2026.

The true twelve-month cost: normalized comparisons

Advertised per-month equivalents mask the upfront outlay and the risk of prepaying for care you may not use. Below we show the upfront commitment, the effective monthly rate over twelve months, the month-to-month alternative, and the total savings—all our calculations from the captured rates.

Found: cash-pay annual plan

Found's cash-pay annual plan requires $2,028 upfront, yielding an effective rate of $169 per month for compounded semaglutide or tirzepatide injection plus the care program. The month-to-month rate is $289, so over twelve months you spend $3,468. The annual plan saves you $1,440 over the year, or $120 per month. Branded medication is billed separately under both plans. (Source: Found pricing captured September 4, 2026.)

Found: insurance-support annual plan

The insurance-support annual plan requires $1,188 upfront for an effective rate of $99 per month; the month-to-month version is $199. Over twelve months the monthly plan totals $2,388, so the annual plan saves $1,200, or $100 per month. Compounded medication is included; typical copays run around $30, but branded medication is billed separately. (Source: Found pricing captured September 4, 2026.)

Ro Body Program: membership only, medication extra

Ro's annual Body Program membership costs $888 upfront—$74 per month effective—while the month-to-month membership is $149. Over twelve months the monthly rate totals $1,788, so the annual plan saves $900, or $75 per month. However, medication is billed separately: Wegovy pill costs $149 to $299 per month depending on dose, and Zepbound vial or pen costs $299 to $449 per month. If you add medication, the true twelve-month cost ranges from $2,676 (annual membership plus lowest Wegovy dose) to $6,276 (annual membership plus highest Zepbound dose). (Source: Ro pricing captured September 4, 2026.)

Henry Meds: compounded semaglutide injection

Henry Meds offers a twelve-month pay-in-full option at $2,364 upfront, or $197 per month effective, for compounded semaglutide injection with provider visits and shipping included. The month-to-month rate is $297, totaling $3,564 over twelve months. The annual plan saves $1,200, or $100 per month. Henry Meds also offers six-month and monthly options; the six-month pay-in-full rate is $1,482 ($247 per month effective). (Source: Henry Meds pricing captured September 4, 2026.)

Hims & Hers: six-month compounded semaglutide

Hims & Hers advertises a six-month compounded semaglutide plan at $1,194 upfront, or $199 per month effective, with medication and clinical access included. The service does not publish a standard month-to-month rate in the evidence captured, and eligibility and dose may affect the offer. Over six months the commitment is $1,194; extrapolating to twelve months at the same rate yields $2,388. (Source: Hims & Hers pricing captured September 4, 2026.)

PlexusDx: three- and six-month options with no annual lock-in

PlexusDx does not require annual prepayment. The service offers three-month and six-month commit periods with lower per-month rates: compounded semaglutide injection is $189 month-to-month, $169 per month on a three-month plan, or $149 per month on a six-month plan. Compounded tirzepatide injection is $289 month-to-month, $269 per month on a three-month plan, or $249 per month on a six-month plan. Pricing is flat at every dose, with no separate membership fee; provider visit, medication, and shipping are all included. Over twelve months, two six-month cycles of semaglutide cost $1,788 total ($149 × 12), compared to $2,268 month-to-month ($189 × 12)—a savings of $480, or $40 per month. (Source: PlexusDx pricing captured September 13, 2026.)

Decision factors: when annual plans work and when they don't

You gain predictability and lower per-month costs

Annual plans lock in your rate for twelve months, insulating you from mid-year price increases. The savings are real: Found's cash-pay annual plan saves $1,440 over twelve months compared to paying monthly; Henry Meds' twelve-month pay-in-full semaglutide plan saves $1,200. If you're confident you'll stay on the same medication and dose for the full year, the discount can justify the upfront outlay.

You lose flexibility if your needs change

GLP-1 treatment is iterative. Dose adjustments, side effects, and goal attainment all change the equation. If you reach your target weight at month eight, or if nausea forces you to stop at month five, most annual plans do not offer prorated refunds. Found, Ro, and Calibrate all require full upfront payment; the sources captured do not specify refund policies for early termination, which means you should assume the prepaid amount is non-refundable. Henry Meds lists "cancel per terms" but does not detail partial refund eligibility in the captured evidence.

Programs that separate membership from medication add hidden costs

Ro's annual Body Program membership costs $888 upfront—$74 per month effective—but medication is billed separately at $149 to $449 per month depending on the drug and dose. Over twelve months your true cost is the $888 membership plus $1,788 to $5,388 in medication, totaling $2,676 to $6,276. Calibrate's $2,388 annual program fee likewise excludes medication, labs, and copays. WeightWatchers Clinic advertises an initial two months at $25 each followed by $74 per month on a twelve-month Med+ plan, but Wegovy pill costs $149 to $299 per month on top of the membership. Always add the medication line to the membership line to see the true twelve-month outlay.

Review reports highlight billing and cancellation friction

Trustpilot and Reddit posts captured September 4, 2026, describe individual experiences with annual-plan lock-ins. One WeightWatchers Clinic user reported being charged after attempting to cancel within the twelve-month commitment window (Trustpilot, captured September 4, 2026). A Hims & Hers user described regret after a six-month renewal processed automatically when the user had intended to pause treatment (Trustpilot, captured September 4, 2026). These are individual reports, not aggregate data, but they illustrate the practical risk: if you prepay and later want out, the path to a refund may be unclear or unavailable.

Shorter commit periods offer a middle path

Three-month and six-month plans reduce upfront risk while still delivering per-month savings. PlexusDx's six-month semaglutide plan costs $149 per month ($894 total for six months), compared to $189 month-to-month—a $240 savings over six months with half the lock-in of an annual plan. Ro offers a six-month Body Program membership at $534 upfront ($89 per month effective), compared to $149 month-to-month. Henry Meds' six-month pay-in-full semaglutide plan is $1,482 ($247 per month effective), compared to $297 month-to-month. If you're uncertain about tolerability or timeline, a six-month commitment gives you most of the discount with less downside.

Choose an annual plan if…

• You have twelve months of prior GLP-1 experience at a stable dose and tolerate the medication well.
• You have the cash to prepay $888 to $2,364 upfront without financial strain.
• You prefer rate certainty and are confident your weight-loss timeline extends at least twelve months.
• You have confirmed in writing that the program offers prorated refunds or penalty-free cancellation if your needs change mid-year (this detail was absent from most sources captured).

Choose a shorter commit period or month-to-month if…

• You are new to GLP-1 medication and have not yet established tolerability or effective dose.
• You expect to reach your goal weight within six to nine months.
• You cannot comfortably prepay four figures without affecting other financial priorities.
• You value the ability to pause, switch medications, or stop treatment without forfeiting prepaid funds.
• You want to test a provider's service quality—responsiveness, prescription turnaround, customer support—before committing long-term.

Where PlexusDx fits

PlexusDx does not offer annual prepay plans. The service uses three-month and six-month commit periods to deliver lower per-month rates without requiring a twelve-month lock-in. Compounded semaglutide injection is $189 month-to-month, $169 per month on a three-month plan, and $149 per month on a six-month plan; compounded tirzepatide injection is $289 month-to-month, $269 per month on a three-month plan, and $249 per month on a six-month plan. Pricing is flat at every dose. There is no separate membership fee; provider visit, medication, and shipping are all included in the per-month rate. Over twelve months, two six-month cycles of semaglutide cost $1,788 total, compared to $2,268 month-to-month—a $480 savings without the upfront outlay or twelve-month commitment required by Found or Henry Meds. PlexusDx works with licensed 503A compounding pharmacies. PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com).

What about other providers with annual or multi-month discounts?

ShedRx

ShedRx advertises tirzepatide at $299 per month, $269 per month on a six-month plan, or $239 per month on a twelve-month plan. Semaglutide is advertised from $149 per month. The sources note conflicting teaser prices on various pages; the product page is designated as the latest. (Source: ShedRx pricing captured September 4, 2026.)

AltRx

AltRx listed compounded semaglutide at $89 month-to-month, $85 per month on a three-month plan, $80 per month on a six-month plan, or $75 per month on a twelve-month plan; compounded tirzepatide was $149 month-to-month, $144 per month on a three-month plan, $130 per month on a six-month plan, or $125 per month on a twelve-month plan. The source notes the promotion was stated to end September 5, 2026, and current rates should be confirmed at checkout. (Source: AltRx pricing captured September 4, 2026.)

Fridays Health

Fridays Health advertises semaglutide from $117 per month and tirzepatide from $190 per month; the advertised figures require multi-month prepayment, and no separate membership is advertised. Fridays Health holds a 4.2-star rating on Trustpilot with approximately 4,700 reviews. (Source: Fridays Health pricing captured September 4, 2026; Trustpilot data captured September 4, 2026.)

IVIM Health

IVIM Health advertises semaglutide from $100 per month and tirzepatide from $183.33 per month, plus a $75 per month membership (first month free); medication bundles are prepaid. (Source: IVIM Health pricing captured September 4, 2026.)

Eden

Eden lists compounded semaglutide at $99 per month for medication plus $99 per month for membership (first month $39), and compounded tirzepatide at $199 per month for medication plus $99 per month for membership (first month $39). Route and availability are clinician-dependent. Eden holds a 4.5-star rating on Trustpilot with approximately 5,000 reviews; one captured one-star review reports an eleven-day order delay and repeated requests for records Eden had previously issued (Trustpilot, captured September 4, 2026). (Source: Eden pricing and Trustpilot data captured September 4, 2026.)

Methodology and freshness

We captured pricing and plan details from provider websites and Trustpilot profiles between September 4 and September 13, 2026. Twelve-month cost comparisons and per-month equivalents for prepaid plans are our calculations, derived by multiplying advertised monthly rates by twelve or dividing upfront totals by the number of months. We confirmed PlexusDx rates on September 13, 2026. Review themes are paraphrased from individual Trustpilot and Reddit posts captured September 4, 2026; they represent individual reports, not aggregate trends, and are cited with platform and capture date. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. When sources conflicted—such as multiple advertised rates for the same plan—we noted the conflict and advised confirming the figure at checkout. Capture dates appear inline throughout the article. All pricing is subject to change; confirm current rates and refund policies with each provider before committing to an annual plan.

Frequently Asked Questions

Can I get a refund if I stop an annual GLP-1 plan early?

Most annual plans require full upfront payment and do not specify prorated refund policies in publicly available terms. Found, Ro, and Calibrate all require twelve-month prepayment; the sources captured did not detail early-termination refund eligibility, so you should assume prepaid amounts are non-refundable unless the provider confirms otherwise in writing before you pay.

Do annual plans cover dose increases or medication switches?

It depends on the provider and the plan structure. Found's annual plans include compounded medication at any dose; PlexusDx six-month plans likewise use flat per-dose pricing. However, programs that bill medication separately—such as Ro and WeightWatchers Clinic—will charge you the applicable medication rate for each dose tier, and that cost is not covered by the annual membership fee.

Is an annual plan cheaper than paying month-to-month over twelve months?

Yes, if you use all twelve months. Found's cash-pay annual plan saves $1,440 over twelve months compared to monthly billing; Ro's annual Body Program membership saves $900; Henry Meds' twelve-month pay-in-full semaglutide plan saves $1,200. However, if you stop early and cannot obtain a prorated refund, the per-month cost of what you actually used may be higher than the month-to-month rate.

What happens if I need to pause treatment mid-year on an annual plan?

Pause policies vary by provider and were not detailed in most sources captured. If you prepay for twelve months and pause at month six, you will likely forfeit the remaining six months of prepaid access unless the provider explicitly offers pause-and-resume terms. Confirm pause and restart policies in writing before committing to an annual plan.

Are three-month or six-month plans a better deal than annual plans?

Three-month and six-month plans offer partial discounts with lower upfront risk. PlexusDx's six-month semaglutide plan saves $240 over six months compared to month-to-month, with half the lock-in of an annual plan. Ro's six-month Body Program membership saves $360 over six months. If you are uncertain about tolerability, timeline, or provider fit, shorter commit periods deliver most of the discount with less downside exposure.

Sources

• PlexusDx pricing, plexusdx.com, accessed September 13, 2026.
• Found pricing and plan details, captured September 4, 2026.
• Ro Body Program pricing, captured September 4, 2026.
• Henry Meds pricing and multi-month options, captured September 4, 2026.
• Hims & Hers six-month plan pricing, captured September 4, 2026.
• Calibrate Metabolic Reset pricing, captured September 4, 2026.
• WeightWatchers Clinic Med+ pricing, captured September 4, 2026.
• PlushCare membership pricing, captured September 4, 2026.
• ShedRx pricing, captured September 4, 2026.
• AltRx pricing and promotion end date, captured September 4, 2026.
• Fridays Health pricing, captured September 4, 2026.
• IVIM Health pricing, captured September 4, 2026.
• Eden pricing, captured September 4, 2026.
• Trustpilot profiles for Found, Ro, Henry Meds, Hims & Hers, WeightWatchers Clinic, Fridays Health, Eden, and PlexusDx, accessed September 4 and September 9, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.